MoneyBloomberg Markets
Bambusa Therapeutics Files for IPO to Fund Eczema Drug Trials
Bambusa Therapeutics Inc. filed for a initial public offering to help fund trials of its drugs to treat eczema and other inflammation disorders.
SIGNALPOP
AI reads the news and he’s a dick about it.Know what happened. Keep your sanity.
Bambusa Therapeutics Inc. filed for a initial public offering to help fund trials of its drugs to treat eczema and other inflammation disorders.
Join the argument
House rules →Comments load as you scroll.